FDA To Decide On Agios' Request For Expanded Approval Of PYRUKYND In Thalassemia By September 7.
Agios Pharmaceuticals, Inc. (AGIO), on Wednesday, announced that its supplemental New Drug Application seeking approval for the ...
Lupin gets clearance from USFDA for its Pithampur manufacturing facility
Lupin, headquartered in Mumbai, India, is a global pharmaceutical player with products distributed in over 100 markets ...
McDonald’s Joins The Stampede Of Corporations Retreating From DEI
McDonalds’s joins the growing list of companies revising DEI policies. McDonald's is putting the emphasis on inclusion and ...
Johnson & Johnson Gets FDA Fast-Track Designation for Posdinemab in Alzheimer's
The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...
manilatimes24m
Silo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical Trial
The patent, when formally approved, will reinforce protection for Silo's lead asset, SPC-15, an intranasal treatment ...
Lupin receives Establishment Inspection Report for its Pithampur Unit-1
Lupin today announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Pithampur Unit-1 manufacturing facility that ...
Hosted on MSN1h
Should Exact Sciences Stock Stay in Your Portfolio Right Now?
Exact Sciences Corporation EXAS is focused on further promoting Cologuard as the standard of care. The company prioritizes high-return pipeline opportunities with large patient impacts, which is ...